T/CYHX 001-2024 Active Group standards

T/CYHX 001-2024 Chuan and Chongqing pharmaceutical industry enterprise credit evaluation standard

T/CYHX 001-2024 Chuan and Chongqing pharmaceutical industry enterprise credit evaluation standard

Publish Date: 2024-10-08 Implement Date: 2024-10-18 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CYHX 001-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: General Principles of Standardization
Publish Date: 2024-10-08
Implement Date: 2024-10-18

Scope

Scope: This document sets forth the terms and definitions, basic principles, evaluation indicators and methods, evaluation process, credit ratings and representation methods, and evaluation result requirements for the credit evaluation of enterprises in the pharmaceutical field in Sichuan and Chongqing. This document applies to the credit rating evaluation and related activities of pharmaceutical enterprises within the administrative areas of Sichuan Province and Chongqing City. Main technical content: Evaluation indicators and methods 1. Evaluation indicators The credit evaluation of enterprises in the pharmaceutical field includes two parts: public credit evaluation and professional credit evaluation. The evaluation indicators include public credit evaluation indicators and professional credit evaluation indicators. The public credit evaluation indicators are common indicators for pharmaceutical production enterprises, wholesale enterprises, and retail chain enterprises, covering six first-level indicators: business management, law-abiding, contract performance, development and innovation, social responsibility, and financial status. Second-level and third-level indicators are also set (see Table A.1 in Appendix A). The professional credit evaluation indicators are set according to the characteristics of pharmaceutical production enterprises, wholesale enterprises, and retail chain enterprises, and second-level indicators are also set (see Tables A.2, A.3, and A.4 in Appendix A). 2. Evaluation methods The credit evaluation of enterprises in the pharmaceutical field adopts a comprehensive scoring method, with a credit score range of [0, 1000]. The total score of public credit evaluation is 1000 points, with a weighting ratio of 60%; the total score of professional credit evaluation is 1000 points, with a weighting ratio of 40%. The final evaluation score of the credit subject = public credit score * 60% + professional credit score * 40%. When the sa

Development Information

Related Standards

Contact Us